EMEA-001073-PIP02-14 - paediatric investigation plan

varicella-zoster virus (inactivated)

Key facts

• Active substance:
  varicella-zoster virus (inactivated)
• Therapeutic area:
  Vaccines
• Decision number:
  P/0043/2017
• PIP number:
  EMEA-001073-PIP02-14
• Pharmaceutical form(s):
  Powder and solvent for suspension for injection
• Condition(s) / indication(s):
  Prevention of Varicella Zoster virus disease
• Route(s) of administration:
  Subcutaneous use
• Decision type:
  P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
• Decision date:
  31/01/2017
• Compliance check done:
  No

Decision

P/0043/2017: European Medicines Agency decision of 31 January 2017 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for varicella-zoster virus (inactiv...

Adopted Reference Number: EMA/12299/2017